Wnt7a PCP Modulator for Symmetrical Stem Cell Division
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for muscular dystrophies and muscle degeneration lack effective methods to modulate stem cell division symmetry, leading to inadequate muscle regeneration and potential stem cell depletion, with existing treatments like myostatin blockers posing risks and side effects.
Innovation Solution
The use of a composition comprising a modulator of planar cell polarity (PCP) signaling, specifically a Wnt7a polypeptide or polynucleotide, to promote symmetrical division of stem cells, thereby expanding the stem cell population and enhancing muscle regeneration without depleting the stem cell reservoir.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If myostatin blockers are used to treat muscular dystrophies, then muscle growth is promoted, but side effects and risks occur
Solution Approach 1:
The patent uses modulators of planar cell polarity (PCP) signaling as intermediary molecules to indirectly promote muscle regeneration through satellite stem cells, rather than directly blocking myostatin. This intermediary approach activates Wnt/PCP signaling pathways that regulate stem cell division symmetry, achieving muscle growth promotion while avoiding the harmful side effects associated with direct myostatin inhibition.
Solution Approach 2:
The invention changes the therapeutic parameter from direct myostatin pathway inhibition to PCP signaling pathway modulation. By targeting different molecular parameters (PCP signaling components instead of myostatin directly), the treatment achieves similar therapeutic outcomes (muscle regeneration) while operating through a different biological mechanism that avoids known side effects.
2Productivity
If stem cells undergo asymmetric division to produce progenitor cells, then muscle repair is enabled, but stem cell population is depleted
Solution Approach 1:
The patent dynamically regulates stem cell division symmetry by modulating PCP signaling. The treatment can shift the balance between symmetric and asymmetric division based on therapeutic needs, allowing the system to adaptively control whether stem cells self-renew or differentiate into progenitor cells for muscle repair.
Solution Approach 2:
The invention changes the division symmetry parameter of stem cells by activating PCP signaling pathways. This parameter change enables the stem cells to transition from predominantly asymmetric division (which depletes the stem cell pool) to symmetric division (which maintains and expands the stem cell population while still enabling muscle repair through controlled differentiation).
Data Source
AI summary
There are provided compositions and methods for modulating stem cell division decisions, in particular, division symmetry. It has been demonstrated that wnt7a acts through frizzled-7 receptor expressed on the surface of adult stem cells, e.g. satellite stem cells, to activate the planar cell polarity (PCP) pathway, thereby promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.